SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Most Read
1. King Salman Hospital brings home two wins at Healthcare Asia Awards 2025 2. India’s healthcare market to reach $638b by 2025 3. Bataan St. Joseph Hospital & Medical Center Corp hailed at Healthcare Asia Awards 2025 4. China issues plan to boost health-related spending 5. Fullerton Health launches first Executive Health Screening Centre in JakartaResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
It brought home the Secondary Hospital of the Year - Saudi Arabia and the Clinical Service Initiative of the Year - Saudi Arabia awards.
